A UK-based subscription-led direct-to-consumer brand specializing in women's hormone health has shown significant growth. This brand operates on a 90-day replenishment cycle with 55-63% of new customers opting for a subscription at checkout. Over a span of 29 months from April 2024 to August 2026, the brand has accumulated 18,400 customers and 26,900 orders, achieving a 37.9% retention rate by the third month for first-order customers. The last twelve months saw a net revenue of £1.25 million at a 62% gross margin. The enterprise operates in an asset-light manner; it has no employees, relying on an outsourced UK third-party logistics provider and a single Shopify store for sales. The founders manage customer service and media, maintaining a lean operation. The customer base is predominantly women aged 35-55 in the UK, with acquisitions largely driven by paid social media advertising on platforms like Meta and TikTok. The brand measures success using its data, noting a blended average order value of around £50 and a customer acquisition cost of £38 over the past year. Notably, the subscriber base stands as a valuable asset, contributing significantly to the company’s revenue and EBITDA. Current forecasts suggest building paid media efforts from a base of £8.5k/month, aiming to broaden its product range and explore additional sales platforms like TikTok Shop and Amazon. Financially, the brand maintains favorable working capital dynamics with 40 days of stock cover against 45 days of credit from suppliers. There are no owner salaries affecting EBITDA, reflecting the seller's discretionary earnings. The business is up for sale due to changes in the founders' personal circumstances, not due to any business-related concerns.